Journals / Türk Kardiyoloji Derneği Arşivi / 2007 / Cilt: 35 - Sayı: 8

Postprandial triglyceride levels in patients with or without metabolic syndrome and their relationship with coronary artery disease

Metabolik sendrom olan ve olmayan hastalarda tokluk trigliserid düzeyleri ve bunun koroner arter hastalığı ile ilişkisi

Pages
482–488
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Our data demonstrate that postprandial triglyceride levels exhibit higher increases and remain high for a longer period in patients with MS, without showing a significant relationship with CAD.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Postprandial triglyceride levels are thought to carry greater risk than fasting levels for coronary artery disease (CAD).
📊
Key Findings & Data:Study design: The study included 122 patients (75 males, 47 females; mean age 59±10 years) whose coronary arteries were examined by coronary angiography within the past six months.
💡
Conclusion & Impact:Conclusion: Our data demonstrate that postprandial triglyceride levels exhibit higher increases and remain high for a longer period in patients with MS, without showing a significant relationship with CAD.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Postprandial triglyceride levels are thought to carry greater risk than fasting levels for coronary artery disease (CAD). We investigated the relationship between CAD and fasting and postprandial hypertriglyceridemia in patients with or without metabolic syndrome (MS). Study design: The study included 122 patients (75 males, 47 females; mean age 59±10 years) whose coronary arteries were examined by coronary angiography within the past six months. The patients were evaluated in four groups according to the presence or absence of CAD and MS, that is, patients, (i) without CAD or MS; (ii) having MS without CAD; (iii) having CAD without MS; and (iv) having both. The diagnosis of MS was made according to the NCEP ATP III criteria. Serum triglyceride levels were measured after 12-hour fasting and at 2, 4, 6, and 8 hours following a lipid loaded breakfast. Results: Metabolic syndrome and CAD were detected in 49 patients (40.2%) and 51 patients (41.8), respectively. Compared to the patients without MS, fasting and postprandial triglyceride levels were significantly higher at all times in patients with MS (p0.05). Post-hoc analyses showed that MS was the only factor that affected triglyceride levels significantly. Conclusion: Our data demonstrate that postprandial triglyceride levels exhibit higher increases and remain high for a longer period in patients with MS, without showing a significant relationship with CAD.

Özet

Amaç: Koroner arter hastalığında (KAH), tokluk trigliserid düzeylerinin açlık düzeylerinden daha fazla risk oluşturduğu düşünülmektedir. Bu çalışmada, metabolik sendrom (MS) olan ve olmayan hastalarda KAH ile açlık ve tokluk hipertrigliseridemi arasındaki ilişki araştırıldı. Çalışma planı: Çalışmaya, son altı ay içinde koroner anjiyografi ile koroner arterleri değerlendirilmiş olan 122 hasta (75 erkek, 47 kadın; ort. yaş 59±10) alındı. Hastalar KAH ve MS varlığına göre dört gruba ayrıldı: (i) KAH olmayan, MS olmayan hastalar; (ii) KAH olmayan, MS olan hastalar; (iii) KAH olup MS olmayan hastalar; (iv) hem KAH, hem de MS olan hastalar. Metabolik sendrom tanısı, NCEP ATP III ölçütlerine göre kondu. Trigliserid düzeyleri, 12 saat açlık sonrasında ve kahvaltıda yağ yüklemesini izleyen 2, 4, 6 ve 8. saatlerde alınan kan örneklerinde ölçüldü. Bulgular: Kırk dokuz hastada (%40.2) MS, 51 hastada (%41.8) KAH saptandı. Metabolik sendromlu hastaların açlıkta ve lipid yüklemesi sonrası yapılan tüm ölçümlerde trigliserid değerleri MS olmayan hastalardan anlamlı düzeyde yüksek bulunurken (p0.05). Post-hoc analizlerde trigliserid düzeylerindeki farkı yaratan faktörün MS olduğu görüldü. Sonuç: Bulgularımıza göre, MS olan hastalarda tokluk trigliserid düzeyleri daha fazla yükselmekte ve daha uzun süre yüksek kalmakta ve bu durum KAH ile anlamlı bir ilişki göstermemektedir.

🔖

Cite This Article

YÜCEL, M., YILDIRIR, A., ÖZİN, B., ATAR, İ., AYDINALP, A., ATAR, A. İ., ÖZGÜL, A. S., ERTAN, Ç., MÜDERRİSOĞLU, H., GÜLMEZ, Ö. (2022). Postprandial triglyceride levels in patients with or without metabolic syndrome and their relationship with coronary artery disease. Türk Kardiyoloji Derneği Arşivi, Cilt: 35 - Sayı: 8, 482–488. https://ajindex.com/articles/633591

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-53
  2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97
  3. International Diabetes Federation [homepage on the Internet]. Brussels, Belgium: The IDF consensus worldwide definition of the metabolic syndrome. Available from:
  4. Grundy SM. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. Am J Cardiol 1998;81:18B-25B
  5. Havel RJ. Role of triglyceride-rich lipoproteins in progression of atherosclerosis. Circulation 1990;81:694-6
  6. Krauss RM. Atherogenicity of triglyceride-rich lipoproteins. Am J Cardiol 1998;81:13B-17B
  7. Nordestgaard BG, Lewis B. Intermediate density lipoprotein levels are strong predictors of the extent of aortic atherosclerosis in the St. Thomas’s Hospital rabbit strain. Atherosclerosis 1991;87:39-46
  8. Ginsberg HN, Jones J, Blaner WS, Thomas A, Karmally W, Fields L, et al. Association of postprandial triglyceride and retinyl palmitate responses with newly diagnosed exercise-induced myocardial ischemia in middle-aged men and women. Arterioscler Thromb Vasc Biol 1995;15:1829-38
  9. Patsch JR, Miesenbock G, Hopferwieser T, Muhlberger V, Knapp E, Dunn JK, et al. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 1992;12:1336-45
  10. Simpson HS, Williamson CM, Olivecrona T, Pringle S, Maclean J, Lorimer AR, et al. Postprandial lipemia, fenofibrate and coronary artery disease. Atherosclerosis 1990;85:193-202
  11. Groot PH, van Stiphout WA, Krauss XH, Jansen H, van Tol A, van Ramshorst E, et al. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb 1991; 11:653-62
  12. Meyer E, Westerveld HT, de Ruyter-Meijstek FC, van Greevenbroek MM, Rienks R, van Rijn HJ, et al. Abnormal postprandial apolipoprotein B-48 and triglyceride responses in normolipidemic women with greater than 70% stenotic coronary artery disease: a case-control study.